Comparison between endothelial and neuronal nitric oxide pathways in rat aorta and gastric fundus

Nitric Oxide - Biology and Chemistry

Volumn 2, Issue 3, 1998, Pages 147-154

  Guilmard, Christine ^a   Auguet, Michel ^a   Chabrier, Pierre Etienne ^a  

^a Institut Henri Beaufour   (France)

Author keywords

Aorta; Gastric fundus; NANC nerves; Nitric oxide synthase; NOS inhibitor

Indexed keywords

1 (TRIFLUORMETHYL)IMIDAZOLE; 1,2,4 OXADIAZOLE[4,3 A]QUINOXALIN 1 ONE; 6 ANILINO 5,8 QUINOLINEQUINONE; 7 NITROINDAZOLE; 8 BROMO CYCLIC GMP; GUANYLATE CYCLASE; N METHYLARGININE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; S METHYLTHIOCITRULLINE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DRUG POTENCY; ENDOTHELIUM CELL; ENZYME INHIBITION; INHIBITION KINETICS; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH FUNDUS;

ANIMALIA;

EID: 0031657447     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1006/niox.1998.0170     Document Type: Article

References (34)

1. Furchgott R. F. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. J. Am. Med. Assoc. 276:1996;1186-1188.
2. Joslyn A. F., Barnette M. S., Grous M., Fudge M., Price W. J., Manning C. D., Thompson W. E., Barone F. C., Ormsbee H. S. III. Cyclic nucleotides increase during neuronally induced relaxation of sphinteric and nonsphincteric gastrointestinal smooth muscle. Gastrointest. Motil. 2:1990;65-72.
3. Torphy T. J., Fine C. F., Burman M., Barnette M. S., Ormsbee H. S. Lower esophageal sphincter relaxation is associated with increased cyclic nucleotide content. Am. J. Physiol. 251:1986;G786-G793.
4. Marletta M. A. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268:1993;12231-12234.
5. Stuehr D. J., Griffith O. W. Mammalian nitric oxide synthases. Adv. Enzymol. Rel. Areas Mol. Biol. 65:1992;287-346.
6. GLin vitro. Br. J. Pharmacol. 99:1990;408-412.
7. Moore P. K., Wallace P., Gaffen Z., Hart S. L., Babbedge R. C. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: Antinociceptive and cardiovascular effects. Br. J. Pharmacol. 110:1993;219-224.
8. Narayanan K., Griffith O. W. Synthesis ofLLSL. J. Med. Chem. 37:1994;885-887.
9. Wolff D. J., Datto G. A., Samatovicz R. A., Tempsick R. A. Calmodulin-dependent nitric oxide synthase. J. Biol. Chem. 268:1993;9425-9429.
10. Handy R. L. C., Wallace P., Gaffen Z. A., Whitehead K. J., Moore P. K. The antinociceptive effect of 1-(2-trifluoromethylphenyl)imidazole (TRIM), a potent inhibitor of neuronal nitric oxide synthase in vitro, in the mouse. Br. J. Pharmacol. 116:1995;2349-2350.
11. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
12. Li C. G., Rand M. J. Nitric oxide and vasoactive intestinal polypeptide mediate non-adrenergic, non-cholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur. J. Pharmacol. 191:1990;303-309.
13. Boecxstaens G. E., Pelkmans P. A., De Man J. G., Bult H., Herman A. G., Van Maercke Y. M. Evidence for a differential release of nitric oxide and vasoactive intestinal polypeptide by nonadrenergic noncholinergic nerves in the rat gastric fundus. Arch. Int. Pharmacodyn. 318:1992;107-115.
14. D'Amato M., Curro D., Montuschi P. Evidence for dual components in the non-adrenergic non-cholinergic relaxation in the rat gastric fundus: Role of endogenous nitric oxide and vasoactive intestinal polypeptide. J. Auto. Nerv. Sys. 37:1992;175-186.
15. Griffith O. W., Kilbourn R. G. Nitric oxide synthase inhibitors: Amino acids. Methods in Enzymology. 1996;Academic Press, San Diego. p. 375-392.
16. Babbedge R. C., Bland-Ward P. A., Hart S. L., Moore P. K. Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br. J. Pharmacol. 110:1993;225-228.
17. Handy R. L. C., Harb H. L., Wallace P., Gaffen Z. A., Whitehead K. J., Moore P. K. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl)imidazole (TRIM) in vitro: Antinociceptive and cardiovascular effects. Br. J. Pharmacol. 119:1996;423-431.
18. Bland-Ward P. A., Moore P. K. 7-Nitro indazole derivatives are potent inhibitors of brain, endothelium and inducible isoforms of nitric oxide synthase. Life Sci. 57:1995;I131-135.
19. Macleod K. M., Harris D. W. NG., Diamond J. Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile response of rat arteries to α-adrenoceptor stimulation. Mol. Pharmacol. 32:1987;59-64.
20. Malta E., Macdonald P. S., Dusting G. J. Inhibition of vascular muscle relaxation by LY83583. Naunyn-Schmiedeberg's Arch. Pharmacol. 337:1988;459-464.
21. Khan M. T., Jothianandan D., Matsunaga K., Furchgott R. F. Vasodilatation induced by acetylcholine and by glyceryl trinitrate in rat aortic and mesenteric vasculature. J. Vasc. Res. 29:1992;20-28.
22. Barbier A. J. M., Lefebvre R. A. Effect of LY83583 on relaxation induced by non-adrenergic, non-cholinergic nerve stimulation and exogenous nitric oxide in the rat gastric fundus. Eur. J. Pharmacol. 219:1992;331-334.
23. Mülsch A., Lückhoff A., Pohl U., Busse R., Bassenge E. LY 83583 (6-anilino-5,8-quinolinedione) blocks nitro-vasodilator-induced cyclic GMP increases and inhibition of platelet activation. Naunyn Schmiedebergs Arch. Pharmacol. 340:1989;119-125.
24. Wolin M. S., Cherry P. D., Rodenburg J. M., Messina E. J., Kaley G. Methylene blue inhibits vasodilation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. J. Pharmacol. Exp. Ther. 263:1990;170-179.
25. Garthwaite J., Southam E., Boulton C. L., Nielsen E. B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H. Mol. Pharmacol. 48:1995;184-188.
26. Lefebvre R. A. Influence of superoxide dismutase inhibition on the discrimination between NO and the nitrergic neurotransmitter in the rat gastric fundus. Br. J. Pharmacol. 118:1996;2171-2177.
27. Auguet M., Delaflotte S., Chabrier P. E., Braquet P. Endothelial and smooth muscle NO synthase in rat isolated aorta. Moncada S., Marletta M. A., Hibbs J. B. The Biology of Nitric Oxide. 1992;211-213 Portland Press.
28. Gillespie J. S., Sheng H. The effects of pyrogallol and hydroquinone on the response to NANC nerve stimulation in the rat anococcygeus and bovine retractor penis muscles. Br. J. Pharmacol. 99:1990;194-196.
29. Martin W., Mcallisterr K. H. M., Paisley K. NANC neurotransmission in the bovine retractor penis muscle is blocked by superoxide anion following inhibition of superoxide dismutase with diethyldithiocarbamate. Neuropharmacology. 33:1994;1293-1301.
30. 2+S. Br. J. Pharmacol. 119:1996;990-996.
31. Furchgott R. F., Jothianandan D., Khan M. T. Comparison of properties of nitric oxide and nitrosocysteine as relaxants of rabbit aorta. Moncada S., Marletta M. A., Hibbs J. B. The Biology of Nitric Oxide. 1992;17-20 Portland Press.
32. Ku D. D. Nitric oxide- and nitric oxide donor-induced relaxation. Packer L. Methods in Enzymology. 1996;107-119 Academic Press, San Diego.
33. Gorbunov N. V., Osipov A. N., Sweetland M. A., Day B. W., Elsayed N. M., Kagan V. E. NO-redox paradox: Direct oxidation of α-tocopherol and α-tocopherol-mediated oxidation of ascorbate. Biochem. Biophys. Res. Commun. 219:1996;835-841.
34. Hogg N., Darley-Usmar V. M., Wilson M. T., Moncada S. The oxidation of α-tocopherol in human low-density lipoprotein by the simutaneous generation of superoxide and nitric oxide. FEBS Lett. 326:1993;199-203.